The necessity for understanding normal human functions and the mechanisms w
hich underlie dysfunction in these processes is essential in the promotion
of a healthier lifestyle. To achieve this goal utilization of a suitable an
imal model is necessary in order to develop new pharmaceutical agents to al
leviate diseases or chemicals to enhance the quality of life. It is incumbe
nt upon investigators to choose a species in which pharmacokinetic principl
es are established and it is important that these phenomena resemble those
of the humans. The choice of rats has specific advantages in that these rod
ents possess similar pharmacodynamic parameters to humans. Other advantages
include availability, low cost, ease of breeding, and an extensive literat
ure data-base to enable comparisons to present findings. However, in the in
terpretation of data from animals to humans, there are factors which need t
o be recognized as playing important roles in chemical-induced outcomes. Th
e confounding factors include strain, supplier, age, gender, hormonal statu
s and dietary intake. The aim of this article is to demonstrate that there
are differences in the responsiveness of rat stock/strains to chemicals and
that lack of consideration of confounding factors yields inappropriate con
clusions regarding risk assessment for humans. (C) 2001 Elsevier Science Ir
eland Ltd. All rights reserved.